NASDAQ:MACK
Merrimack Pharmaceuticals, Inc.
- Stock
Last Close
15.12
15/05 20:00
Market Cap
189.75M
Beta: 1.80
Volume Today
372.58K
Avg: 70.31K
PE Ratio
−152.04
PFCF: −135.35
Dec '13 | Dec '14 | Dec '15 | Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
net income | -130.69M - | -83.56M 36.06% | -147.79M 76.87% | -153.52M 3.88% | -58.72M 61.75% | -60.94M 3.77% | -21.27M 65.10% | -3.03M 85.76% | -2.46M 18.92% | -1.54M 37.11% | -1.18M 23.51% | |
depreciation and amortization | 2.59M - | 3.22M 24.49% | 4.29M 33.04% | 6.25M 45.73% | 5.22M 16.45% | 4.07M 21.97% | 2.23M 45.31% | |||||
deferred income tax | 17.82M - | -42.40M 337.94% | -7.70M 81.85% | -1.50M 80.51% | ||||||||
stock based compensation | 10.73M - | 13.20M 22.96% | 15.35M 16.32% | 14.87M 3.17% | 12.79M 13.97% | 3.05M 76.15% | 2.37M 22.26% | 1.72M 27.37% | 397K 76.95% | 71K 82.12% | 160K 125.35% | |
change in working capital | 18.87M - | 22.96M 21.69% | 14.57M 36.54% | -61.66M 523.17% | -19.60M 68.21% | -6.96M 64.51% | -8.16M 17.37% | -1.18M 85.55% | 1.98M 268.14% | 176K 91.13% | -64K 136.36% | |
accounts receivables | 3.41M - | 2.59M 24.13% | -3.17M 222.54% | -10.99M 246.56% | 175K 101.59% | 100K 42.86% | ||||||
inventory | 4.04M - | 827K 79.51% | -3.72M 549.46% | -9.69M 160.64% | -8.48M 12.51% | -993K 88.28% | ||||||
accounts payables | 13.30M - | -646K 104.86% | 13.56M 2,198.61% | -3.87M 128.54% | -9.28M 139.80% | -3.80M 59.03% | -12.08M 217.84% | -1.94M 83.91% | -208K 89.30% | 27K 112.98% | -148K 648.15% | |
other working capital | -1.88M - | 20.19M 1,173.58% | 7.90M 60.87% | -37.12M 569.78% | -2.02M 94.56% | -2.26M 11.92% | 3.92M 273.17% | 764K 80.50% | 2.19M 186.91% | 149K 93.20% | 84K 43.62% | |
other non cash items | 3.32M - | 9.37M 182.37% | 8.22M 12.25% | 6.00M 26.97% | -43.22M 819.90% | 2.88M 106.66% | -5.04M 275.04% | -2.14M 57.53% | -144K 93.27% | -445K 209.03% | -437K 1.80% | |
net cash provided by operating activities | -95.17M - | -34.81M 63.43% | -105.36M 202.68% | -170.24M 61.59% | -145.94M 14.28% | -65.59M 55.06% | -31.37M 52.17% | -4.63M 85.26% | -218K 95.29% | -1.74M 699.08% | -1.52M 12.63% | |
investments in property plant and equipment | -9.86M - | -6.04M 38.77% | -12.79M 111.91% | -3.15M 75.33% | -915K 71.00% | -118K 87.10% | ||||||
acquisitions net | 3.26M - | -4.00M 222.87% | 7.80M - | |||||||||
purchases of investments | -112.92M - | -111.83M 0.97% | -84.26M - | -103.06M - | -18.59M - | |||||||
sales maturities of investments | 95.10M - | 111.86M 17.62% | 87.90M 21.42% | 84.16M 4.25% | 52.50M - | 51.50M 1.90% | 6M - | |||||
other investing activites | -59K - | -2K 96.61% | -3.26M - | 581.81M 17,963.31% | 28.07M 95.17% | 10.53M 62.51% | 2.14M 79.68% | 144K 93.27% | 445K 209.03% | 139K 68.76% | ||
net cash used for investing activites | -27.74M - | -6.01M 78.33% | 75.11M 1,349.54% | -3.26M 104.34% | 576.89M 17,812.34% | -22.60M 103.92% | 69.83M 408.99% | 2.14M 96.94% | 144K 93.27% | 445K 209.03% | -12.45M 2,897.53% | |
debt repayment | -40M - | -229.66M - | -15M - | |||||||||
common stock issued | 26.72M - | 38.56M - | 3.36M 91.28% | 3.99M 18.83% | 145K - | 239K - | 6.53M 2,633.47% | 521K 92.03% | ||||
common stock repurchased | 6.92M - | -145K - | ||||||||||
dividends paid | -3K - | -7K 133.33% | -140M - | -26.70M - | ||||||||
other financing activites | 123.57M - | 11.43M 90.75% | 181.60M 1,489.11% | 6.05M 96.67% | -288K 104.76% | 14.63M 5,180.56% | -840K 105.74% | -56K 93.33% | ||||
net cash used provided by financing activities | 150.29M - | 11.42M 92.40% | 180.16M 1,477.48% | 9.42M 94.77% | -359.04M 3,913.07% | 14.63M 104.08% | -42.54M 390.73% | -56K 99.87% | 239K 526.79% | 6.53M 2,633.47% | 521K 92.03% | |
effect of forex changes on cash | ||||||||||||
net change in cash | 27.37M - | -29.40M 207.40% | 149.92M 609.96% | -164.08M 209.45% | 71.92M 143.83% | -73.55M 202.28% | -4.08M 94.45% | -2.54M 37.74% | 165K 106.49% | 5.24M 3,073.33% | -13.45M 356.88% | |
cash at beginning of period | 37.71M - | 65.09M 72.58% | 35.69M 45.17% | 185.61M 420.08% | 21.52M 88.40% | 94.22M 337.73% | 20.66M 78.07% | 16.58M 19.76% | 14.04M 15.33% | 14.20M 1.18% | 19.44M 36.87% | |
cash at end of period | 65.09M - | 35.69M 45.17% | 185.61M 420.08% | 21.52M 88.40% | 93.44M 334.12% | 20.66M 77.89% | 16.58M 19.76% | 14.04M 15.33% | 14.20M 1.18% | 19.44M 36.87% | 5.99M 69.19% | |
operating cash flow | -95.17M - | -34.81M 63.43% | -105.36M 202.68% | -170.24M 61.59% | -145.94M 14.28% | -65.59M 55.06% | -31.37M 52.17% | -4.63M 85.26% | -218K 95.29% | -1.74M 699.08% | -1.52M 12.63% | |
capital expenditure | -9.86M - | -6.04M 38.77% | -12.79M 111.91% | -3.15M 75.33% | -915K 71.00% | -118K 87.10% | ||||||
free cash flow | -105.03M - | -40.84M 61.11% | -118.14M 189.27% | -173.40M 46.77% | -146.85M 15.31% | -65.71M 55.26% | -31.37M 52.26% | -4.63M 85.26% | -218K 95.29% | -1.74M 699.08% | -1.52M 12.63% |
All numbers in USD (except ratios and percentages)